Celgene Corporation (United States)

Celgene Corporation, now part of Bristol-Myers Squibb, was a biopharmaceutical company focused on cancer and inflammatory disease treatments. Known for Revlimid (lenalidomide) and Pomalyst (pomalidomide) for multiple myeloma, Thalomid for multiple myeloma and leprosy complications, and Otezla (apremilast) for psoriasis and psoriatic arthritis. Celgene’s legacy of hematology and immunology innovation continues through BMS’s oncology leadership.